Drug Database
Back to search

France· FR:69913202

NICARDIPINE ARROW 10 mg/10 mL, solution injectable

A nicardipine product containing chlorhydrate de nicardipine, registered in France by EUGIA PHARMA (MALTA) (MALTE). The same ATC class is registered in 8 of our 19 countries.

ATC C08CA04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNICARDIPINE ARROW 10 mg/10 mL, soluti…ATCC08CA04REGISTER NO.FR:69913202PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de nicardipineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nicardipine is registered in 8 of 19 countries.

Countries holding a registration under ATC C08CA04 (nicardipine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose
Search nicardipine products by name

Nicardipine · ATC C08CA04

8 / 19 countries

  • Belgiumprice
  • Franceprice
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE NICARDIPINE
Manufacturer
EUGIA PHARMA (MALTA) (MALTE)
Country
France (FR)
ATC code
C08CA04
ATC class
Nicardipine
Defined daily dose
90 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400941686474
    10 ampoule(s) en verre brun de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

228 interactions on record for nicardipine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nicardipine against other medicinesHow interaction checks work

Nicardipine · interactions on record

228 records

  • 8 severe
  • 173 moderate
  • 1 minor
  • 46 info

Most severe, free to view

  • DolasetronA04AA04severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • MitotaneL01XX23severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nicardipine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nicardipine products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Nicardipine Aguettant, Nicardipine Hikma
  • Spain · Flusemide, Nerdipina Retard
  • United Kingdom (Northern Ireland) · Nicardipine Hydrochloride Tillomed Laboratories, Nicardipine Laboratoire Aguettant
  • Italy · Nicardipina Mylan Generics
  • Luxembourg · Nicardipine Aguettant, Rydene Iv
  • Netherlands · Cardene Iv

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d08905b0-4a35-4e3c-b9db-00a74ac6b576
GET /v1/drugs/d08905b0-4a35-4e3c-b9db-00a74ac6b576?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69913202",
  "date_amm": "2011-04-08",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE NICARDIPINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about nicardipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console